Peripheral Interventions Areas of Interest

The Investigator-Sponsored Research (ISR) Program provides a unique opportunity for physicians to explore areas of mutual scientific interest and build scientific knowledge of disease management while partnering with Boston Scientific.

Boston Scientific provides support for well-written, scientifically sound studies that further the understanding of diseases and their treatment with the ultimate goal of transforming patients' lives.

This global program is open to all qualified researchers who are interested in conducting their own research.

The suggested research of particular therapies may not be consistent with their indications for use.

In the event there are submissions that may need additional regulatory approvals, it will be the Sponsor's or researcher's responsibility to obtain approval from appropriate regulatory bodies.

Further details about our 2021 areas of interest are shown below.

If you have any questions, please email PI_External_Research@bsci.com.

Keyword Search
Clear All Search Keywords

Sort Title ↑	Description	Sponsor	Created

	Interventional Oncology - All products Expanding the use of products in other clinical indications	1/27/2021

	Interventional Oncology - Cryoablation Cryoanalgesia for pain	2/12/2021

	Interventional Oncology - Embolization Trans-radial embolization procedures	1/27/2021

	Interventional Oncology - Embolization Benign embolization indications	1/27/2021

	Interventional Oncology - Embolization Use of beads in the treatment of mCRC	1/27/2021

	Interventional Oncology - Microwave ablation Data regarding the use of microwave ablation	1/27/2021

	Interventional Oncology - TheraSphere Use of TheraSphere in the treatment of mCRC	1/27/2021

	Interventional Oncology - TheraSphere TheraSphere dosimetry in non-HCC indications especially mCRC	1/27/2021

	Interventional Oncology - TheraSphere Sequencing TheraSphere with systemic treatments including immunotherapies and chemotherapies	1/27/2021

	Interventional Oncology - TheraSphere TheraSphere vs stereotactic body radiation therapy (dosimetry perspective)	1/27/2021

First 1 Last

10 Results: